HEKTAŞ decided to acquire Agriventis Technologies from Australia, which develops seeds that are tolerant to drought, that is one of the effects of global climate change, and Arma Pharmaceuticals (İlaç), which produces veterinary medical products during the period when the importance of animal health as well as human health increased with the epidemic.
In the statement made by HEKTAŞ to the Public Disclosure Platform (KAP), it was stated that the entire Arma Pharmaceuticals and 51 percent of Agreventis will be purchased.
The share transfer prices of both companies will be determined by independent valuation institutions. HEKTAŞ will start production of Mung Bean with Agriventis primarily through contracted farming method. As of 2021, Black Sesame will also be produced in addition to Mung Bean.
Aiming to enrich its veterinary medical product portfolio with its collaborations with Arma Pharmaceuticals, research and development activities, HEKTAŞ will focus on increasing its strength in the field of animal health and its share in both domestic and international markets.